Manila, Philippines – In a surprising move, President Rodrigo Duterte has issued an official directive barring his cabinet members from participating in any ongoing investigations into the controversial Pharmally Pharmaceutical Corporation scandal, a decision that has sparked both confusion and criticism among lawmakers and the public.

The ban comes after several cabinet members were called to testify before the Senate Blue Ribbon Committee, which is investigating the company’s involvement in the multi-billion peso government contracts for pandemic-related supplies. Pharmally has been at the center of controversy over alleged overpricing and questionable procurement practices, with several officials accused of collusion in awarding these contracts.

A Shocking Directive

In a televised address, President Duterte explained that the directive was meant to protect the integrity of his administration and avoid any perceived conflict of interest. He also expressed concerns over the ongoing political implications of the investigation, citing the need for a fair process that would not be clouded by partisan politics.

“I have instructed my cabinet members to refrain from participating in the Senate probe, as it is not for them to meddle in ongoing investigations,” said President Duterte. “The focus should be on ensuring transparency, not on personal or political interests.”

Mixed Reactions from Lawmakers and the Public

The president’s directive has been met with a mix of reactions from both the public and key figures in the legislature. Opposition lawmakers have expressed concern that the decision could hinder efforts to uncover the truth and hold those responsible accountable for the alleged irregularities.

Senator Richard Gordon, who has led the Senate investigation into Pharmally, called the move “unfortunate” and argued that cabinet members who were involved in the procurement process should be compelled to testify.

“It’s critical that all relevant officials, including those in the cabinet, be held accountable,” said Senator Gordon. “This directive only raises more questions about the government’s involvement in this scandal.”

What Lies Ahead?

With the ban now in place, it remains to be seen how the Senate will proceed with its investigation. Observers are closely watching whether the directive will affect the ongoing efforts to probe the contracts awarded to Pharmally and whether the public will continue to demand accountability.

As the controversy unfolds, the Pharmally scandal continues to dominate national discussions, with many Filipinos calling for transparency and justice in government dealings.